A short-term assessment of nascent HIV-1 transmission clusters among newly diagnosed individuals using envelope sequence-based phylogenetic analyses by Kafando, Alexis et al.
A Short-Term Assessment of Nascent HIV-1 Transmission
Clusters Among Newly Diagnosed Individuals Using
Envelope Sequence-Based Phylogenetic Analyses
Alexis Kafando,1 Bouchra Serhir,2 Florence Doualla-Bell,2 Eric Fournier,2
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Abstract
The identification of transmission clusters (TCs) of HIV-1 using phylogenetic analyses can provide insights into
viral transmission network and help improve prevention strategies. We compared the use of partial HIV-1
envelope fragment of 1,070 bp with its loop 3 (108 bp) to determine its utility in inferring HIV-1 transmission
clustering. Serum samples of recently (n = 106) and chronically (n = 156) HIV-1-infected patients with status
confirmed were sequenced. HIV-1 envelope nucleotide-based phylogenetic analyses were used to infer HIV-1
TCs. Those were constructed using ClusterPickerGUI_1.2.3 considering a pairwise genetic distance of £10%
threshold. Logistic regression analyses were used to examine the relationship between the demographic factors
that were likely associated with HIV-1 clustering. Ninety-eight distinct consensus envelope sequences were
subjected to phylogenetic analyses. Using a partial envelope fragment sequence, 42 sequences were grouped
into 15 distinct small TCs while the V3 loop reproduces 10 clusters. The agreement between the partial
envelope and the V3 loop fragments was significantly moderate with a Cohen’s kappa (j) coefficient of 0.59,
p < .00001. The mean age (<38.8 years) and HIV-1 B subtype are two factors identified that were significantly
associated with HIV-1 transmission clustering in the cohort, odds ratio (OR) = 0.25, 95% confidence interval
(CI, 0.04–0.66), p = .002 and OR: 0.17, 95% CI (0.10–0.61), p = .011, respectively. The present study confirms
that a partial fragment of the HIV-1 envelope sequence is a better predictor of transmission clustering. How-
ever, the loop 3 segment may be useful in screening purposes and may be more amenable to integration in
surveillance programs.
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Introduction
In 2015, a total of 609 HIV cases were reported to thePublic Health Laboratory in Quebec (LSPQ), including
299 new diagnoses.1 To better characterize transmission
patterns,2,3 we evaluated molecular epidemiology methods
using phylogenetic analyses of HIV genome sequences ob-
tained from infected individuals. Pairwise genetic distances
(PWDs) derived from env, gag, and pol nucleotide sequences
were used to assess the relationship between sequences and
therefore define study HIV transmission dynamics.4,5 Com-
bining sequence-based clustering with risk factors and so-
ciodemographic, clinical, and geographical parameters may
help identify patterns of transmission in the HIV-infected
population.6–11
The env gene, encoding glycoproteins gp120 and gp41, is
the most variable region of the HIV-1 genome.12–14 GP120
contains five hypervariable regions (V1 to V5) and five
conserved regions (C1–C5).15–18 The gp41 region consists of
three domains, the ectodomain (ECD), the transmembrane
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domain, and the long cytoplasmic domain.19 Each subre-
gion and each domain of the env play a key role in HIV
pathogenesis.16,18,20
In the literature, pol gene-derived sequences are mostly
used for phylogenetic analysis to infer HIV-1 transmission
clustering.4 It is readily available in clinical laboratories
performing drug resistance testing in most countries.
However, little is known about the potential of HIV-1
envelope-derived sequences for this application.21,22 It has
been shown that within-host env genetic diversity is sig-
nificantly associated with HIV-1 Fiebig stage and disease
progression.23,24 The HIV-1 evolution in a new recipient
may recover some ancestral features of infected donors,25
such as the genetic distance between the donor and recipi-
ent.21,26 Such characteristics may be used to establish the
closely transmitted network (cluster) between HIV-infected
individuals.
The first objective of this study was to assess the potential
of HIV env-derived sequences (1,070 bp) to determine HIV-1
transmission clustering. The second objective was to inves-
tigate whether shorter portions of the env gene, such as the
env V3 loop-derived sequences (108 bp), could be a valuable
tool to achieve the same mean while reducing technical, time,
and cost constraints27,28 associated with partial but long-
length env sequencing. The third objective was to identify
risk factors associated with HIV transmission clustering.
Materials and Methods
Patients and specimens
Serum samples that were reactive in Quebec diagnostic
laboratories using a screening HIV 1/2 immunoassay (EIA)
were submitted to the LSPQ for confirmation by Western blot
(WB) and/or p24 EIA. Positive p24 antigen samples were de
facto classified as recent infections. Samples from newly
confirmed HIV-1 individuals by WB were then submitted to a
recent infection testing algorithm (RITA) based on antibody
avidity. The latter combines a Centers for Disease Control
and Prevention (CDC)-modified Bio-Rad Avidity Assay and
a Sedia-LAg-Avidity assay.29 Recent infections were defined
as a sample that was positive for HIV-1 p24 antigen or pos-
itive for HIV-1 antibodies by WB but classified as ‘‘recent’’
by RITA (£136 days of infection). Established infections
were defined as samples positive by WB and classified as
long-standing by RITA (>136 days of infection).
Based on these criteria, we selected 262 newly diagnosed
HIV samples that included recent (n = 106) and long-standing
(n = 156) infections collected in 2015. The risk factors and
clinical and epidemiological parameter data reported for each
sample were extracted from the HIV provincial surveillance
program.
Amplification and sequencing of partial
envelope fragment
Amplification and sequencing protocols were conducted as
previously described by Kafando et al.30 Briefly, total nucleic
acids were extracted from 100 lL of serum using an auto-
mated BioRobot MDx extraction platform. HIV-1 RNA was
amplified using the Superscript III One-Step RT-PCR system
with Platinum Taq DNA polymerase (Invitrogen, Thermo
Fisher Scientific, and Carlsbad, CA) with primers env-up
forward (5¢-GTTTCTTTTAGGCATCTCCTATGGCAGGA
AGAAG-3¢, HXB2 positions 5957–5983) and env-lo reverse
(5¢-GTTTCTTCCAGTCCCCCCTTTTCTTTTAAAAAG-3¢,
HXB2 positions 9063–9088).31 Nested amplification was per-
formed using the Expand High Fidelity PCR System Kit
(Roche Diagnostics, Indianapolis). Primers E60F forward
(5¢-TAATCAGTTTATGGGATCAAAGC-3¢, HXB2 posi-
tions 6547–6569)32 and E55R reverse (5¢-GCCCCAGAC
TGTGAGTTGCAACAGATG-3¢, HXB2 positions 7940–
7914),33 were used, generating PCR products covering
&1,400 bp of the env gene. Amplification conditions, library
preparation, and Illumina MiSeq next-generation sequencing
(NGS) were conducted as previously described.30 Following
quality control with FastQC (http://www.bioinformatics
.babraham.ac.uk/projects/fastqc), raw sequence reads were
de novo assembled using the Iterative Virus Assembler
(IVA)34 to generate a consensus sequence.
Sequence data processing, phylogenetic analysis,
and HIV transmission cluster reconstruction
All consensus env nucleic acid sequences were aligned
with molecular evolutionary genetic analysis, using MEGA7
software (www.megasoftware.net) under ClustalW meth-
ods.35 All aligned sequences were submitted to MAFFT
multiple sequence alignment software version 736 to verify
the reliability of the alignments. The human immunodefi-
ciency virus type 1 K03455.1 (HXB2) env nucleotide se-
quence (nt) positions (6225 to 8795) were included in the
alignment to serve as a reference. Matching sequences, ex-
cluding gaps with equal lengths (HXB2 nt positions 6831 to
7900& 1,070 bp) in this case, were selected for phylogenetic
analyses. The env partial fragment analyzed included the
gp120-C2 to C5 subregions (HXB2 nt positions 6813 to
7757) and the gp41 partial ECD (HXB2 nt positions 7758 to
7915). The HIV-1 env gp120-V3 loop sequences (HXB2
genome nt positions 7110 to 7217& 108 bp) were also ana-
lyzed separately. Phylogenetic trees were constructed in
MEGA7 using the maximum likelihood algorithm, and their
reliability was estimated from 1,000 bootstrap replicates.
Transmission clusters (TCs) were evaluated among se-
quences that grouped around common proximal nodes with
‡99% bootstrap, as supported by a previous study.11 In the
present study, in the absence of the gold standard for HIV-1
envelope sequence-based clustering, we considered a PWD
of £10% as a threshold, as suggested by Novitsky et al.21 The
HIV-1 transmission clustering was defined as two or more
HIV-1-infected individual genomic sequences whose bran-
ches were grouped under a genetic distance threshold in the
phylogenetic tree.4 The interpretation of the extent of the
relevant transmission clustering depended on the genetic
distance threshold, the time that it was established, the
number sequence data set, the sampling densities, the node
bootstrap, and the HIV-1 genomic region concern.4,21 We
considered a high PWD (£10%) to define clustering for the
HIV-1 envelope because it presented the highest variability
compared with GAG and Pol (PWD £1.5%). The extent of
the HIV TC was classified as unique (1 member), small (2–4
members), or large (5–60 members) in the transmission
chain.6 We used ClusterPickerGUI_1.2.3 (http://hiv.bio.ed
.ac.uk/software.html) to construct cluster trees37 and FigTree
v1.4.3 (http://tree.bio.ed.ac.uk/software/figtree/) to view them.
We used Dendroscope version 3.5.10 to build a Tanglegram
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of connected taxa between rooted phylogenetic trees and
networks.38,39 The NCBI subtyping tool40 was used to de-
termine HIV viral subtypes, which was confirmed by the
REGA HIV-1 subtyping tool version 3.41
Statistical analyses
We used bivariate and multivariate analyses to determine
the independence of associations between exposed variables
(epidemiologic and clinical factors) and outcome (clustering).
Categorical variables were compared using a chi-square or
Fisher’s exact test, and continuous variables were compared
using a two-sample Student’s t-test or Wilcoxon rank sum test.
All variables with p < .25 as a cutoff point from bivariate
analysis were included in the multivariate analysis using lo-
gistic regression. At this point, p < .0542,43 using the Wald test
was considered to be statistically significant, and selected
variables were included in the final regression model. Statistics
analyses were performed in SPSS version 24 and STATA
version 14. The determination of agreement between env
gp120-V3 sequence clusterings determining with a partial env
fragment as a gold standard to correctly identify individuals in
a cluster tree was assessed using Cohen’s kappa coefficient.
The estimated parameters were sensitivity, specificity, positive
predictive value, and negative predictive value. Stata IC ver-
sion 14 was used as a statistical package, and a p value less
than 5% was considered statistically significant.
Ethics statement
All work was conducted in accordance with the Declara-
tion of Helsinki in terms of informed consent. All samples
were anonymized before we accessed them for this study. No
nominal information was used for analysis or data manage-
ment. Ethical approval was given and renewed yearly by our
Institutional Review Board (IRB): the ‘‘Comité d’éthique et
de la recherche des Centres hospitaliers affiliés à l’Université
de Montréal’’.
Results
Amplification and DNA sequencing of HIV-1 env were
attempted on 262 specimens and were successful for 39% of
them (n = 102) (Fig. 1). This moderate level of amplification
success could be mediated by multiple factors affecting the
specimen quality such as the long-term storage of serum,
viral RNA extraction procedures and enzymes used in the
PCR amplification as well as the viral loads of infected in-
dividuals (VL < 20,000 copies/ml). In addition, depending on
the length the HIV-1 envelope sequence to be amplified, this
procedure is known to be challenging.27,28
Of the included HIV-1 env sequences (n = 102), 47%
(n = 48) and 35% (n = 36) were classified as chronic and re-
cent HIV infections, respectively, using the RITA (26),
whereas 18% (n = 18) were found to be recent as confirmed
by EIA-p24 testing (Fig. 1). The demographic characteristics
are described in Table 1. Briefly, 34% of individuals were
asymptomatic, whereas 13% of individuals presented acute
HIV infection symptoms, and 11% had reached the AIDS
stage (Table 1). The mean CD4 count in total population was
375 cell/mm3, range [5–1,150]. The mean HIV-1 viral load in
total population was 4.94 log10 copies/ mL, range [1.60–
8.20], and the mean age was 38.8 years, range [18–78]. Of the
102 individuals, 79.4% were infected with HIV-1 subtypes B,
and 20.6% with HIV-1 non-B subtypes. Age and baseline
CD4+ T cell counts were significantly different between the
recent and chronic infections using the Wilcoxon rank sum
test. The mean age of recently infected individuals was 34.15,
range [18–78], and for chronic infections, it was 44.03, range
[21–58], p = .0002. The mean baseline CD4+ T cell count was
521, range [12–1,150] in recent infections and 186, range [5–
698] in chronic infections.
FIG. 1. Flowchart of HIV-1 envelope se-
quences used in this study. The figure pres-
ents the total number of specimens sampled
(n = 262) and the final sequences obtained
after amplification, sequencing, and sequence
analysis processes (n = 102). EIA, enzyme
immunoassay; RITA, recent infection testing
algorithm.
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HIV-1 partial envelope fragment-length
sequence-based clustering using
phylogenetic analysis
From the 102 sequences analyzed, 4 were excluded be-
cause of insufficient env length. Finally, 98 sequences with
satisfactory and similar lengths were included in the phylo-
genetic analysis. Of these 98 sequences, 57.14% (n = 56) did
not form clusters, whereas 42.85% (n = 42) were part of 16
small clusters ranging from two to five individuals using the
partial env fragment length (1,070 bp) at a distance cutoff of
0.1 (Fig. 2). The HIV-1 subtype B envelope sequence re-
presented 93.3% of clusters identified (n = 14/15) and were
labeled Clust1 to 15, except for Clust4 that was constituted by
HXB2 and BAL reference sequences. The non-B HIV-1
subtypes, which represented 7.14% and 6.7% (n = 1/15), la-
beled Clust16, are shown in Figure 2.
Sequences from recently HIV-1-infected individuals were
mostly represented in clusters; 50% were (n = 27/54) in-
volved, whereas 31.21% (n = 15/48) comprised chronic in-
fections (Fig. 2). The inclusion or noninclusion in clusters for
acutely and chronically HIV-1-infected individual envelope
sequences was statistically significant using the chi-square
test as follows: odds ratio (OR): 0.4, p = .02.
HIV-1 envelope gp120 loop 3 (V3) sequence-based
clustering using phylogenetic analysis
Phylogenetic analyses using only the V3 loop (108 bp)-
derived sequences were also performed to identify HIV-1
TCs. The env loop 3 sequence-based clustering reproduced
66.66% (n = 10/15) of the TCs observed with the partial env
fragment length (Fig. 3). Five clusters labeled (Clust3, 5, 11,
Table 1. Population Characteristics
Variable characteristics Recent Chronic Total
Gender, n (% of individuals)
Female 1 (1.90) 13 (28.20) 14 (14.14)
Male 52 (98.10) 33 (71.80) 85 (85.86)
Risk factor for HIV acquisition, n (% of individuals)
MSM 36 (85.71) 19 (48.72) 55 (67.90)
Heterosexual 0 3 (7.69) 3 (3.70)
Relationship with at-risk heterosexual 2 (4.76) 2 (5.13) 4 (4.94)
Endemic country 1 (2.38) 13 (33.33) 14 (17.28)
MSM/IDU 3 (7.14) 0 3 (3.70)
IDU 0 2 (5.13) 2 (2.47)
Place of birth, n (% of individuals)
Canadian 27 (65.85) 19 (48.72) 46 (57.50)
Caribbean 3 (7.32) 6 (15.38) 9 (11.25)
Europe 5 (12.20) 1 (2.56) 6 (7.50)
North Africa and Middle East 1 (2.44) 0 1 (1.25)
Sub-Saharan Africa 2 (4.83) 10 (25.64) 12 (15)
Latin, Central, and South America 4.88 2 (5.13) 4 (5)
Asia 1 (2.44) 0 1 (1.25)
Aboriginal (First Nations) 0 1 (2.56) 1 (1.25)
HIV subtype, n (% of individuals)
B 45 (83.30) 36 (75.00) 81 (79.40)
Non-B 9 (17.70) 12 (25.00) 21 (20.60)
Age, n [mean; range] 31 [18–78] 46.5 [21–77] 37 [18–78]
15–24 years 12 2 14
25–34 years 23 11 34
35–44 years 6 7 13
45–54 years 7 19 26
55–64 years 4 5 9
>64 years 1 2 3
Baseline CD4+ T cell count (cells/mm3), no.
of individuals [median; range]
42 [458.5; 12–1,150] 36 [175; 5–698] 78 [375; 5–1,150]
>500 19 [710; 506–1,150] 3 [609; 580–698] 22 [700; 506–1,150)
351–500 11 [415; 390–490] 7 [420; 360–485] 18 [417.5;360–490)
201–350 8 [250; 217–320] 5 [302; 220–340] 13 [252; 217–340)
£200 4 [185; 12–200] 21 [59; 5–196] 25 [63; 5–200]
HIV viral load (log10 copy/mL), no. of
individuals [median; range]
42 [4.94; 3.43–8.20] 38 [4.76; 1.60–6.34] 80 [4.90;1.60–8.20]
>5 20 [5.53; 5–8.20] 15 [5.60; 5.15–6.34] 35 [5.60; 5–8.20]
<5 22 [4.46; 3.43–.96] 23 [4.25; 1.60–4.98] 45[4.27;1.60–4.98]
Table presents the repartition of demographic, epidemiologic, clinical, and risk factors of the study population by infection status (recent
or chronic).
IDU, injecting drug user; MSM, men who have sex with men.
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13, and 14), shown in Figure 2, were not observed when using
the env V3 sequence-based clustering (Fig. 3). However, it
identified an additional cluster (Clust6) (Fig. 3) that was not
detected by the partial env fragment length analyses.
Agreement between the HIV-1 partial envelope
fragment lengths of the V3 loop-derived sequences
as independent tools to perform HIV-1
transmission clustering
The env-V3 sequence-based clustering reproduced 10 of
the 15 clusters previously identified with the env 1,070 bp
sequence length. An additional cluster (C6) was identified
only with env-V3 loop sequence-based clustering, shown in
Figure 4.
The sensitivity, specificity, positive predictive value, and
negative predictive value of env gp120-V3 in determining
TCs were 70%, 98.6%, 95.5%, and 88.8%, respectively,
compared with the partial env fragment length (1,070 bp)-
derived sequences as the gold standard (Table 2). The con-
cordance between the gold standard and env gp120 V3 cluster
determination was assessed by Cohen’s kappa coefficient and
demonstrated a significantly moderate agreement, j = 0.59,
p < .00001 (Table 2).
Agreement between the partial HIV-1 envelope
fragment sequence lengths with the gp120 C2V3C3
region-derived sequences as independent tools
for identifying HIV-1 TCs
We also compared the partial env fragment length
(1,070 bp) with the gp120 C2V3C3 regions (HXB2 nt posi-
tions 6813 to 7376& 564 bp) to improve the moderate sen-
sitivity associated with the V3 sequence-based clustering
identification. Surprisingly, the gp120 C2V3C3 regions
identified only 6 of the 15 clusters (40%) observed using the
partial env fragment sequence at PWD of £10%. This unex-
pected result represented less than the number of clusters
identified by V3 loop-derived sequences alone, estimated to
be 66.66% compared with the same gold standard.
Description of factors associated with
HIV transmission clustering
The recently HIV-1-infected subjects defined by RITA29
represented 53.4% of the TCs, followed by acutely infected
individuals (EIA-p24+) at 23.3% and chronically infected
individuals at 23.3% (Fig. 1 and Table 1). The HIV-1 sub-
types B and D comprised 93% and 7% of clusters, respec-
tively. The distribution of the HIV-1 TCs by epidemiologic,
clinical, and risk factors of acquisition is presented in Table 3.
The mean age of HIV-1-infected individuals included in
clusters was 33.34 years [18–58], the mean CD4 count was
390.22 cell/mm3 [10–871], and the mean HIV-1 viral load
was 5.12 log10 copies/mL [1.60–8.20]. Mean age (<38.8 vs.
‡38.8 years) and HIV-1 subtype (B vs. non-B) were identified
as two factors significantly associated with HIV-1 TCs: mean
age (OR = 0.25, 95% confidence interval [CI, 0.04–0.66],
p = .002) and HIV-1 subtype (OR = 0.17, 95% CI [0.10–0.61],
p = .011) (Table 4).
Discussion
HIV-1 envelope sequence inference was used to reveal
HIV-1 transmission clustering (network) among newly di-
agnosed individuals in 2015 in Quebec, Canada. The first
analyses used a partial env fragment length (1,070 bp) that
identified 15 small TCs, including 42 HIV-infected individ-
uals. Using only the env gp120 V3 sequences (108 bp), we
identified 11 small clusters, thus reproducing 66.7% (10/15)
of clusters that were previously detected by the partial- env
fragment sequence length, which have been considered as the
gold standard. We used the envelope loop 3 (V3) fragment as
comparison because it is the most conserved of the HIV-1 env
hypervariable regions, and its sequences are frequently used
to predict coreceptor tropism44–50 and may be available for
intention-to-treat analysis using entry inhibitors in clinics.
The agreement between these two approaches was mod-
erate (Cohen’s kappa coefficient (j) = 0.59). We tested dif-
ferent cutoff values of V3 sequences (1% to 20%) compared
with partial env fragment sequences, but they did not enhance
the accuracy of the agreement of the approaches. This ob-
servation underlies and confirms that the length of HIV-1
genome sequences analyzed inflects on TC determination.26
Therefore, using only env V3 loop sequences may underes-
timate HIV-1 TCs.
Although we included two constant regions of the gp120
(C2, C3) with the V3 loop and compared with the HIV-1
partial env fragment in the hope of increasing the degree of
sensitivity of a number of cluster estimates, unexpectedly, the
sequence derived from the gp120_C2-V3-C3 regions iden-
tified only 40% of the clusters, which is lesser than the
number of clusters identified by the sequences derived from
the V3 loop alone (66.66%) compared with the HIV-1 partial
env fragment. The three regions decreased the sensitivity
associated with the use of a larger fragment comprising two
constant regions and the V3 loop. It may be that not all have a
good degree of conservation of the nucleotide sequences. The
nucleotide sequence diversity introduced by the two constant
regions (C2 and C3) may have contributed to increasing
the genetic distance threshold between individuals up to
‰
FIG. 2. Molecular phylogenetic reconstruction of HIV-1 TCs among newly and chronically HIV-infected individuals in
2015 in Quebec using partial env-derived sequences (1,070 bp). The cluster tree contains 101 sequences from HIV-1-
infected individuals, including 98 from the study cohort and 3 reference sequences introduced in the analyses as controls
(AF443074.1_C, AY426110_BaL, and K03455.1-HXB2). A total of 42 HIV-1 individuals’ sequences are grouped into
16 distinct small HIV-1 TCs. These clusters are labeled from Clust1 to Clust16 and are depicted using different colors.
The cohort-derived clusters are shown in blue for subtype B (Clust1 to Clust15, except Clust4) and orange for subtype
D (Clust16). The control sequence names are shown in red (Clust4). Sequences that did not form a cluster are shown in
black. Each depicted cluster satisfied ‡99% support on bootstrap resampling of 1,000 replicates and 10% of pairwise
distance.21 CH, chronic HIV-1 infection sequences; p24, recent infection status determined by p24 antigen positivity; RITA,
recent infection status determined by RITA29; TCs, transmission clusters. Color images are available online.
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FIG. 3. Molecular phylogenetic reconstruc-
tion of HIV-1 TCs among newly and chroni-
cally HIV-infected individuals using env
gp120 V3 loop-derived sequences (108 bp).
The cluster tree contains 101 sequences from
HIV-1-infected individual’s env-V3 sequences,
including 98 from the study cohort and 3 ref-
erence sequences introduced in the analyses as
controls (AF443074.1_C, AY426110_BaL, and
K03455.1-HXB2). Each tip represents an in-
dividual patient. A total of 31 HIV-1 se-
quences grouped into 11 distinct small HIV-1
TCs with two to five members per cluster.
These clusters are labeled from Clust1 to
Clust11 and are depicted using different col-
ors. Clusters including sequence names are
shown in blue for subtype B (Clust2 to
Clust11) and orange for subtype D (Clust1).
The control sequence names are shown in red.
Sequences that did not cluster are shown in
black. Each depicted cluster satisfied ‡99%
support on bootstrap resampling of 1,000
replicates and 10% of pairwise distance.21 CH,
chronic HIV-1 infection sequences; p24, re-
cent infection status determined by p24 anti-
gen positivity; RITA, recent infection status






























































































































































>10–15%, contributing to reduce the sensitivity of the esti-
mated number of clusters. We believe that increasing the
length of the sequence up to 524 bp, including only constant
regions (C2, C3 with V3), may not increase the degree of
sensitivity of cluster estimates compared with partial env
fragment length.
However, the small number of env sequence data sets used
in this study did not yield formal conclusions. Further studies
including a large env sequence data set and the combination
of different env segments can help confirm the present result.
We have proceeded to new phylogenetic analyses con-
cerning the gp120 C2V3C3 clustering and reached the same
conclusions. We will consider in the future a large sequence
data set and may evaluate different segments of the envelope
sequence.
However, in screening for public health surveillance pur-
poses, it may be useful as V3 loop sequencing techniques are
routinely performed in clinical laboratories to inform virus
tropism and the use of CCR5 inhibitors in treatment. A recent
study has shown that the V3 loop is one of most predictable
segments of the HIV-1 envelope and that using its sequences
contributes to estimating the recency of an infection.30
Hence, it may also be useful for real-time HIV-1 TC detec-
tion in complementing existing methods.
Previous studies have already demonstrated that the near
full-length genome sequences (9,719 bp) of HIV-1 are the
best tool for estimating the extent of HIV clusters.26,51
However, the methodological and cost constraints associated
with full-genome sequencing preclude its use in routine
clinical epidemiology studies. The estimate of HIV TCs (size
and extent) depends on the selected gene and sequence
length.21 It may negatively (underestimation) or positively
(overestimation) affect the following: the cutoff value de-
fined as genetic distance,21 the type of sequencing (Sanger or
NGS), the number of sequences in data sets, the number of
variable sites or the period covered by the study,4,26 the
timely availability of sequence data,52 and the molecular
phylogenetic methods used for transmission chain defin-
ing.4,53,54 This study covered a 1-year period (2015) that may
underestimate transmission events occurring outside of this
period. If sequencing is performed on a regular basis, it may
help track the early founder of nascent clusters before the
growth that will be identified in the following periods and
help adapt prevention strategies for at-risk populations.
Considering CDC Guide, June 2018, the identification of
most linked sequences over a short period of time could
possibly indicate that transmission occurs rapidly within a
group.55
The cutoff value of the PWD used for this study was £10%,
as proposed by Novitsky et al.21 We considered these cutoff
values because they are not a gold standard concerning HIV
envelope sequence-based clustering, and the study by No-
vitsky et al.21 is the most recent and the method used (PWD)
to define clustering was adapted to the present study than
others. Using a small cutoff value may underestimate cluster
sizes and, on the contrary, using a large cutoff value may
overestimate them. Therefore, the cutoff value has to be well
defined5,8,21,56,57 according to the study by Novitsky et al.21
Specially, in considering the specificity of each the different
HIV-1 subtypes and CRFs, it may be also important to de-
termine the best cutoff value when using the full-length HIV-
1 envelope fragment (GP160) or its specific subregions or
domain (GP120, GP41)-derived sequences for cluster esti-
mates and established correlation between these tools. Fur-
ther studies that may also evaluate the performance of using
the near full-length HIV-1 genome and its three regions
(GAG, Pol, and Env) adjusted by subtypes as independent
tools for determining HIV-1 TCs are also encouraged using
large sequence data sets.
Compared with earlier studies conducted by Brenner
et al.8,58,59 in Québec for longer periods of time and using a
large sequence data set of the HIV-1 pol region (n = 1,277),
30 large TCs (20+/cluster) occurring over 13 years (2002 to
2015)59 were identified. Lubelchek et al. also conducted a
similar study in Chicago using a large data set of pol gene
sequences and identified a single large TC in a total of 26
clusters observed.11 Many HIV-1 TC studies have used pol
gene sequences as these sequences are often available from
clinical laboratories performing drug resistance testing (53).
These findings contrast those of the present study, where no
large cluster has been identified. The reason for the difference
may be due to the limited env sequence data used in this study
(n = 102) and the restricted period (1 year).8,11,58,59 Never-
theless, for this 1-year period, we were able to identify and
highlight the existence of HIV-1 clustering between newly
HIV-1-diagnosed patients. The present study aimed to track
the nascent or forming clusters in real time to help adapt early
prevention strategies that may limit the formation of large
clusters.
Bivariate analysis identified that newly HIV-1-infected
individuals are significantly more associated with HIV-1
transmission clustering than chronically infected individuals,
OR = 2.20, p = .04, using Fisher’s exact test. This observation
is in agreement with results presented by Brenner et al.,59
Dennis et al.,52,60 and Miller et al.61 The results may be
explained by the extreme fitness early founder viruses that
successfully establish infections62–64 and the higher viral
load during acute infection.
Multivariate analyses identified two factors that were
likely associated with TCs: the mean age (<38.8 years) and
the HIV-1 B subtype. Individuals younger than 38.8 years
were more likely to form TCs than those older than 38.8
Table 2. Performance of the env gp120-V3
Sequences in Determining HIV Transmission
Clustering Compared with the Use
of the Full env Fragment
Accuracy parameters Value % (n/N) 95% CI
Sensitivity 61.9 (26/42) 45.6–76.4
Specificity 95.0 (57/60) 86.1–99
Positive predictive value 89.7 (26/29) 72.6–97.8
Negative predictive value 78.1 (57/73) 66.9–86.9
Table presents the performance of the env gp120-V3 sequence-
based clustering (108 bp) using partial HIV-1 envelope fragment
length (1,070 bp) as the gold standard. The sensitivity and
specificity were 61.9% (45.6–76.4) and 95% (86.1–99), respec-
tively. In addition, the positive predictive value and negative
predictive value were 89.7% (72.6–97.8) and 78.1% (66.9–86.9),
respectively. Furthermore, significant and moderate agreement was
documented using Cohen’s kappa coefficient (j = 0.59, p < .00001).
CI, confidence interval; n, number of clusters identified by env
gp120 V3 loop-derived sequences; N, number of clusters identified
by the gold standard.
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years, OR = 3.01, p = .001 (bivariate analysis), and
OR = 0.25, p = .002 (multivariate analysis). This result re-
flects the profile of the HIV epidemics in Quebec, Canada,
where individuals aged between 30 and 39 years accounted
for 28% of reported cases in 2016.65 Individuals infected by
the HIV-1 B subtype were more likely to form clusters
(OR = 0.17) than non-B subtypes, OR = 5.57, p = .009 (bi-
variate analysis), and OR = .0.17, p = .01 (multivariate
analysis). This finding also reflects the most prevalent sub-
type circulating in Quebec. The HIV-infected men who have
sex with men (MSM) population is generally infected by HIV-
1 B viruses and represents a large proportion of new cases in
Quebec (67.90%).65
The objective of the present study was to evaluate tools to
detect newly HIV-infected individuals who have the potential
to transmit and sustain HIV epidemics as early as possible.
Newly HIV-infected individuals are generally unaware of
their infection status66,67 and therefore can contribute to the
spread of infection.61,68 High viral loads observed during
acute infection69–71 also constitute a factor that enhances HIV
transmission of newly HIV-infected individuals. HIV-1 viral
load (>10,000 copies/mL) and CD4 counts >350 generally
constitute biological factors significantly associated with
HIV-1 transmission clustering.57 Our study did not find a sig-
nificant association of viral load or CD4 counts with clus-
tering. The difference may be due to the fact that only 23% of
Table 3. Summary Statistics of the Distribution of HIV-1 Transmission Clusters by Factors
Parameters
HIV transmission clustering
No (%) Yes (%)
Age
<38 23 (39.66) 27 (65.85)
‡38 35 (60.34) 14 (34.15)
Gender
Male 46 (79.31) 39 (95.12)
Female 12 (20.69) 2 (4.88)
HIV-subtype
B 42 (70) 39 (92.86)
Non-B 18 (30) 3 (7.14)
Ethnicity
White 34 (85) 25 (83,33)
Black 16 (4) 5 (16.16)
Motivation for HIV testing
Symptomatic person 25 (50) 16 (51.61)
Screening in an asymptomatic person 17 (24) 13 (41.94)
Confirmation of previous positive test 8 (16) 2 (6.45)
HIV-1 clinical status
Asymptomatic 19 (38) 15 (48.39)
Acute infection 18 (36) 12 (38.71)
Symptomatic infection + AIDS 13(26) 4 (12.90)
HIV transmission risk factors
MSM 32 (64) 23 (74.19)
MSM/IDU+IDU 3 (6) 2 (6.45)
Heterosexual 15(30) 6 (19.35)
Log10 HIV viral load
<5 29 (59.18) 15 (48.39)
‡5 20 (40.82) 16 (51.61)
CD4 count value
<350 24 (51.06) 14 (45.16)
‡350 23 (48.94) 17 (54.84)
HIV infection status by test
Chronic infection by RITA29 33 (55) 15 (35.71)
Acute/early infection by EIA-p24 testing 9 (15) 10 (23.81)
Recent by RITA29 18 (30) 17 (40.48)
HIV-1 infection status
Recent (acute/early recent by RITA) 27 (45) 27 (64.29)
Chronic 33 (55) 15 (35.71)
Bold values illustrate the number of recent versus chronic HIV-1 infection sequences include or non-include in HIV-1 transmission
clusters.
Table presents the summary statistics of the demographic, epidemiologic, clinical, and risk factors of HIV-1-infected individuals
associated with inclusion in or not in clusters.
EIA, enzyme immunoassay; RITA, recent infection testing algorithm.
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clusters occurred in individuals with acute infection; there-
fore, all other clusters occurred in individuals with dampened
viral load (chronic or recent infection <6 months). The timing
of viral load assessment after diagnostic testing might also
be a factor. Bivariate analysis identified gender (male) as
significantly associated with TCs, OR = 5.08, p = .02. This
reflects the HIV epidemic profile in Québec, with MSM
being the highest at-risk group.1 In contrast to studies
conducted in the United States by Lubelchek et al.11 and
Paz-Bailey et al.,72 the black race was not significantly
associated with clusters in the present study. This finding
reflects the demographics of the HIV epidemic of Quebec,
where black people are not overrepresented.1,65 In gen-
eral, the results of this study suggest the importance of
Table 4. Factors Associated with HIV-1 Transmission Clustering Using Logistic Regression Analysis
Factors
Bivariate analysis Multivariate analysis
n p OR 95% CI P
Ethnicity
Black 21 .74 NS
Nonblack 60 Ref.
Gender
Male 85 .041 NS
Female 14 Ref
Age (mean) S
<38.8 years 52 .001 0.25 0.04–0.66 .002
‡38.8 years 47 Ref.
HIV transmission route NS
MSM intercourse 55 .18
Heterosexual intercourse 21 .83
IDU and MSM/IDU intercourse 5 Ref.
Motivation for HIV testing NS
Screening in an asymptomatic person 30 .20
Symptomatic person 41 .27
Confirmation of previous positive test 10 Ref.
Clinical status NS
Acute infections 13 .94
Chronic infection symptoms 6 .18




B 81 .009 0.17 0.10–0.61 .011
Non-B 21 Ref.
HIV-1 infection status NS
Recent by RITA29 + recent by EIA-p24+ 54 .057
chronic by RITA29 48 Ref
CD4 cell count (cells/mm3) NS
‡500 22 .895
<500 56 Ref
HIV-1 viral load (copies/mL) NS
‡100,000 36 .345
<100,000 44 Ref.






Table presents results of logistic regression analysis, including bivariate analysis showing that the HIV-1 subtype, gender, and mean age
of infected individuals were statistically significant ( p < .05). However, all factors with a p value £.25 were subjected to multivariate
analysis. For multivariate analysis, HIV-1 subtype (B vs. non-B), OR = 0.25 (0.04–0.66), p = .002, and patient mean age (<38.8 years
compared with those aged ‡38.8 years), OR = 0.17 (0.10–0.61), p = .011, constitute two factors significantly associated with HIV-1
transmission clustering in this study population.
Bold values illustrate statistically significant results.
Ref: variable of comparison. The statistically significant variables were indicated by their p values.
NS, statistically nonsignificant; OR, odds ratio; S, statistically significant.
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real-time follow-up of transmission networks regarding the
early clusters of transmission established in a single year
from newly HIV-infected individuals. The short-term as-
sessment of early cluster building may help improve quick
responses to prevent HIV transmission by identifying the
nascent or forming clusters and populations at high risk.
Conclusion
Our results confirm the presence of small HIV TCs
among HIV-1-infected individuals in Quebec. HIV subtype
B-infected individuals and individuals younger than 38.8
years are two factors significantly associated with HIV trans-
mission clustering. The HIV-1 partial env fragment length-
derived sequences were able to detect clusters of transmission
contributing to the persistence of the HIV epidemic in Que-
bec. Although less sensitive than the sequencing of partial
env fragments, the V3-derived sequences were able to iden-
tify HIV TCs with moderate agreement. The latter tools (V3
sequence) may be useful for short-term assessment of nascent
HIV-1 transmission clustering in support of the existing
methods in screening purposes.
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from the ‘‘Université du Québec en Outaouais, UQO,’’ Que-
bec, Canada, and Adama Kazienga, Hasselt University, Fa-
culty of Science, Belgium, for their statistical analysis support.
We thank Drs. Andrés Finzi, Petronela Ancuta, and Ni-
colas Chomont of the Hospital Research Center of the Uni-
versity of Montreal (CRCHUM) for their advise on study
conception. Special thanks to the HIV-1-infected patients of
Quebec from whom serum samples were used in the present
study.
Sequence Data
All HIV-1 envelope nucleotide sequences for partial
fragment sequences were deposited and are available in the
GenBank Sequence Database (NCBI) under accession num-
bers KY946519 to KY946713.
Author Disclosure Statement
No competing financial interests exist.
Authors’ Contributions
C.L.T., H.C., A.K., B.S., C.M., F.D.-B., E.F., A.C., and
M.E.-F.: contributed to the conception and design of this
study. A.K., E.F., B.S., C.M., F.D.-B., M.S., A.C., and H.C.:
contributed to acquisition, analysis, and interpretation of
data. A.K., E.F., M.N.S., B.S., C.M., F.D.-B., and H.C.:
contributed to the bioinformatic and statistical analysis of
data. All authors contributed to drafting the work and revising
it critically for important intellectual content and provided
final approval of the version to be published.
Funding Information
This study was supported by the Islamic Development
Bank, the ‘‘Fonds de recherche du Québec—Santé’’ (FRQS),
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